Stock listing

GANX Stock Price, News, Filings & Events — Gain Therapeutics, Inc.

Selected listing: GANX · NASDAQ · USD · US

This page tracks Gain Therapeutics, Inc.'s GANX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GANX:NASDAQ. GANX:NASDAQ is the stock-level entry point for investors researching Gain Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gain Therapeutics, Inc. (ticker: GANX) is a public company based in the United States, with a market capitalization of approximately $72.9 million. The company focuses on developing innovative therapies for various diseases. Gain Therapeutics is committed to advancing its research and development efforts to bring new treatment options to market.